Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Neuroblastoma × Potassium Iodide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1 Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 20 Isotretinoin 14 Topotecan 12 Irinotecan 12 Etoposide 12 Temozolomide 10 Doxorubicin 10 dinutuximab 9 Magnetic Resonance Spectroscopy 9 sargramostim 8 Vincristine 8 Melphalan 8 Filgrastim 7 Cisplatin 7 Granulocyte-Macrophage Colony-Stimulating Factor 6 Granulocyte Colony-Stimulating Factor 6 3-Iodobenzylguanidine 6 Specimen Handling 5 Carboplatin 5 fludarabine 4 etoposide phosphate 4 aldesleukin 4 X-Rays 4 Stem Cell Transplantation 4 Radiotherapy 4 Phantoms, Imaging 4 Mesna 4 Colony-Stimulating Factors 4 Busulfan 4 Biopsy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03332667 2025-04-16

MIBG With Dinutuximab +/- Vorinostat

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Completed

45 enrolled 16 charts

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡